Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Dangers of Tattoos - Even the New ECHA Proposals are Not Enough to Guarantee Safe Inks


News provided by

European Academy of Dermatology and Venereology (EADV)

12 Sep, 2018, 13:06 GMT

Share this article

Share toX

Share this article

Share toX

PARIS, Sept. 12, 2018 /PRNewswire/ --

Tattoos have definitely become mainstream, but possible dangers from tattoo inks include bacterial contamination, allergies, toxic effects and eventually the risk of cancer. Two in three people report side-effects after getting a tattoo. Even the new proposals developed by the European Chemical Agency (ECHA) are insufficient to guarantee safe inks without risk of toxicity and cancerogenicity. At the EADV Congress which opened today in Paris, the EADV reiterates its demand that tattoo inks should be properly tested and should at least meet the same safety standards as cosmetic products.

Tattooing has gained tremendous popularity in Western countries. In Australia, Finland France and Germany, approximately 10% of the populations have at least one tattoo [1]. The 'tattoo craze' is particularly strong among the young generation, in which every third or fourth person has a tattoo. This form of body art has definitely become mainstream. It is remarkable, therefore, that European requirements and restrictions regarding the composition of tattoo inks are still not enough to guarantee safety. Potential dangers from tattoo ink include bacterial contamination, allergies and the risk of toxic effects. Even more so, given that two in three people report some side-effects after getting a tattoo; for example, sun-sensitivity is a common finding. Although there is still a lack of reliable epidemiological studies, even the risk of cancer has to be considered.

Although health and safety regulations have been established by the Council of Europe, resolution ResAp2008(1) [2], focusing on hygiene rules to prevent infections (e.g. so that diseases such as Hepatitis B and HIV are not transmitted by sharing needles, etc.), tattooing is not without its risks. The quality and sterility of tattoo inks, which are generally not controlled, still give reason for concern. A Danish study [3] of bacterial contamination of 58 new inks showed that 10% of the inks are contaminated with bacteria, i.e. Staphylococci, Streptococci, Pseudomonas species and Enterococcus/Coli. These contaminated inks may lead to infection, especially in people at risk (e.g. people with heart diseases, diabetes and patients with a weak immune system).

Allergies and toxicity are further points of concern. The requirements and the restrictions of resolution ResAp2008(1) regarding the composition of tattoo and PMU inks are insufficient to guarantee safety. Tattoo inks consist of pigments and dyes, additives and even nano-particulate traces of heavy metals, as well as hazardous impurities from the production process. Tattoo colorants may release carcinogenic aromatic amines and polycyclic aromatic hydrocarbons. In many cases, the ingredients and chemicals are not clearly labelled. The market is poorly controlled. Some pigments used in tattoo inks are not listed by the Scientific Committee for Consumer Products (SCCP), an advisory body to the European Commission, and therefore are not allowed in cosmetics. Moreover, illegal products and counterfeits of poor quality can easily be purchased on the internet.

On request of the European commission, ECHA (European Chemical Agency) has prepared two pathways for improving the composition of tattoo inks; these have now been submitted for public consultation and for comments from the Member States, and their final publication is expected at the end of 2018. "Unfortunately, the ECHA proposals are still insufficient to guarantee safe inks without any risk of toxicity and cancerogenicity", explains Dr. Christa De Cuyper, MD, Board member of the European Academy of Dermatology and Venereology (EADV). "To eliminate carcinogenic substances and to limit long-term toxic effects, strict measures and well-defined safety limits for the used substances are needed with appropriate analytical methods for controlling such use; the ECHA proposals do not provide adequate solutions to meet these requirements." According to the expert, a positive list of safe products should be developed. The inks should be tested for their potential toxicity, phototoxicity, substance migration, carcinogenicity and possible metabolic conversion. "Tattoo inks should at least meet the same safety standards as cosmetic products", postulates Dr. De Cuyper. "It would even be preferable if they were as safe as medicines because they are injected under the skin. There is scientific evidence that tattoo ink ingredients are transported into the body. The can be found e.g. in draining lymph glands. In laboratory settings they are also detected in the liver of mice." As a consequence, both the EADV and the European Society on Tattoo and Pigment Research (ESTP) are strongly demanding better regulation.

Tattooists and their clients need safe and reliable products. It is the responsibility of the authorities to assure (and protect) public health.

Progress has been made in matters of hygiene, at least. The European Committee for Standardization (Centre Europeèn de normalization/CEN) finalized hygiene standards this year, which will be published at the end of 2018. They give an overview of good practice (procedure), instruments, organization and infrastructure of the tattoo parlour and requirements for training of tattooists. These new standards will be discussed on Friday morning in a meeting with tattooists and tattooist trainers at the Musée des Moulages of l'Hôpital Saint Louis during the EADV Congress, which opened today in Paris.

About EADV

Founded in 1987, EADV is a non-profit association whose vision is to be the premier European Dermato-Venereology Society, with the key aims of improving the quality of patient care, providing continuing medical education (CME) for all Dermato-Venereologists in Europe, and advocacy on behalf of the specialty and patients.

For further information about the Academy, please contact us under +32-2-650-00-90 or visit www.eadv.org.

Contact

Ruel Jacob, Media Coordinator - EADV Office
+32-485-477478

References

[1] Kluger N. Epidemiology of tattoos in industrialized countries. Curr Probl Dermato. 2015; 48: 6-20

[2] Resolution ResAP(2008)1 on requirements and criteria for the safety of tattoos and permanent make-up (superseding Resolution ResAP(2003)2 on tattoos and permanent make-up): https://search.coe.int/cm/Pages/result_details.aspx?ObjectId=09000016805d3dc4  

[3] Høgsberg T, Saunte DM, Frimodt-Møller N et al. Microbial status and product labelling of 58 original tattoo inks. J Eur Acad Dermatol Venereol 2013; 27(1): 73-80

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.